137 related articles for article (PubMed ID: 9713414)
21. From fee-for-service to capitation: factors driving ESRD reimbursement system change.
Day LM
Nephrol News Issues; 1997 Apr; 11(4):22-3, 31. PubMed ID: 9287685
[No Abstract] [Full Text] [Related]
22. Annual facility survey of providers of ESRD therapy. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S178-86. PubMed ID: 9259701
[No Abstract] [Full Text] [Related]
23. The USRDS and its products. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S20-37. PubMed ID: 9713405
[No Abstract] [Full Text] [Related]
24. Excluded from universal coverage: ESRD patients not covered by Medicare.
Thamer M; Ray NF; Richard C; Greer JW; Pearson BC; Cotter DJ
Health Care Financ Rev; 1995; 17(2):123-46. PubMed ID: 10157372
[TBL] [Abstract][Full Text] [Related]
25. Patient mortality and survival. USRDS. United State Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S86-106. PubMed ID: 9259695
[No Abstract] [Full Text] [Related]
26. Hospitalization. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S145-59. PubMed ID: 9259699
[No Abstract] [Full Text] [Related]
27. Medicare HMOs reveal unique contracting strategies for new ESRD risk demonstration.
Public Sect Contract Rep; 1997 May; 3(5):74-6. PubMed ID: 10174874
[No Abstract] [Full Text] [Related]
28. Patient mortality and survival. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S69-80. PubMed ID: 9713409
[No Abstract] [Full Text] [Related]
29. XIII. Analytical methods in ESRD.
Am J Kidney Dis; 1999 Aug; 34(2 Suppl 1):S152-76. PubMed ID: 10431012
[No Abstract] [Full Text] [Related]
30. Causes of death. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S107-17. PubMed ID: 9259696
[No Abstract] [Full Text] [Related]
31. End-stage renal disease, managed care, and capitation: implications for the renal community.
Rubin RJ; Gaylin DS; Shapiro JR
Adv Ren Replace Ther; 1997 Oct; 4(4):306-13. PubMed ID: 9356682
[No Abstract] [Full Text] [Related]
32. The effect of insurance status on use of recombinant erythropoietin therapy among end-stage renal disease patients in three states.
Thamer M; Richard C; Ray NF; Greer JW; Cotter DJ; Pearson BC
Am J Kidney Dis; 1996 Aug; 28(2):235-49. PubMed ID: 8768919
[TBL] [Abstract][Full Text] [Related]
33. The USRDS Dialysis Morbidity and Mortality Study: Wave 2. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S67-85. PubMed ID: 9259694
[No Abstract] [Full Text] [Related]
34. How CROWNWeb will validate and utilize patient data.
Delva O
Nephrol News Issues; 2010 Feb; 24(2):30-3. PubMed ID: 20333989
[No Abstract] [Full Text] [Related]
35. Renal transplantation: access and outcomes. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S118-27. PubMed ID: 9259697
[No Abstract] [Full Text] [Related]
36. The USRDS and its products. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S21-39. PubMed ID: 9259691
[No Abstract] [Full Text] [Related]
37. USRDS: the United States Renal Data System.
Am J Kidney Dis; 2003 Dec; 42(6 Suppl 5):1-230. PubMed ID: 14655174
[No Abstract] [Full Text] [Related]
38. Caring for ESRD patients.
Andriote JM
Healthplan; 1998; 39(4):33-5. PubMed ID: 10351321
[No Abstract] [Full Text] [Related]
39. 1998 U.S. Renal Data System report. Incidence rate remains steady, improvements seen in survival.
Nephrol News Issues; 1998 Sep; 12(9):18-9, 23. PubMed ID: 9923292
[No Abstract] [Full Text] [Related]
40. HCFA: failing to acknowledge the unique characteristics of the ESRD patient.
Kanter A; Nidetz M
Nephrol News Issues; 1990 Feb; 4(2):23-6, 31. PubMed ID: 2320135
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
